{"disease":{"id":"gastroesophageal-junction-adenocarcinoma-siewert-ii-iii","name":"gastroesophageal junction adenocarcinoma siewert ii iii"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06163729","title":"Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction Adenocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":68,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}